Filing Details
- Accession Number:
- 0001104659-21-077703
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-07 16:31:15
- Reporting Period:
- 2021-06-03
- Accepted Time:
- 2021-06-07 16:31:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1722964 | Y-Mabs Therapeutics Inc. | YMAB | Pharmaceutical Preparations (2834) | 474619612 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1753185 | Johan Wedell-Wedellsborg | C/O Weco Group A/S Rungsted Strandvej 113 Rungsted Kyst G7 2960 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-06-03 | 30,666 | $33.19 | 4,415,935 | No | 4 | S | Indirect | By WG Biotech ApS |
| Common Stock | Disposition | 2021-06-04 | 3,841 | $34.03 | 4,412,094 | No | 4 | S | Indirect | By WG Biotech ApS |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By WG Biotech ApS |
| No | 4 | S | Indirect | By WG Biotech ApS |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $33.165 to $34.19. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provideupon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $34.00 to $34.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provideupon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares.
Billionaire Hedge Funds
